Industria farmaceutica

Shaping the Future of Pharmaceutical Manufacturing with Smart Solutions.

Pharmaceutical Lab Operator

Esplora i nostri prodotti

Markets

Our portfolio includes single units, modular systems and complete production lines for powder processing, oral solid dosage forms, parenterals, liquids, semi-solids and nutraceuticals. So, wherever you are, whatever the scale of your operation or indication, we have the capability to make your concept a reality, optimize your process, improve your production efficiency and deliver the ongoing support to make your business a success.

Test before you invest.

Committed to advancing our customers’ research and development activities, GEA’s pharmaceutical technology test centers provide global technical support and know-how to the pharmaceutical industry.
These centers of excellence give you access to a full range of test facilities and teams of experts, all of whom work closely with our customers to optimize processes and evaluate their products, enabling them to achieve their process and production goals in a cost-effective way.

Workers working at Hovione

Advancing continuous pharmaceutical manufacturing

GEA and partners innovate flexible continuous processing technologies, transforming pharmaceutical development and manufacturing for a modernized future.

biopharma industry

I separatori a perfusione accelerano i processi biofarmaceutici

Le piccole aziende di produzione biofarmaceutica sono spesso la forza trainante a cui si deve la proliferazione di trattamenti medici innovativi. GEA sta rivoluzionando le capacità di raccolta delle cellule per questi produttori con separatori a perfusione che consentono un processo continuo ottimizzato per l'efficienza. Per la prima volta, i separatori a dischi adatti sono stati trasformati in macchine compatte monouso che consentono di risparmiare spazio, manodopera e fatica, creando al tempo stesso la possibilità di aumentare la produzione e la velocità.

Prodotti e tecnologie

Visualizzazione di 4 su 45

Downloads

Approfondimenti GEA

GEA Globe

GEA reports profitable growth for 2025 and expects accelerated revenue growth

GEA’s past fiscal year was one of significant growth and further profitability gains. In particular, the technology group substantially increased order intake, with all divisions contributing here. GEA also made progress in all Mission 30 strategic growth areas. In addition, GEA met key interim targets under its climate plan ahead of schedule. Major milestones in fiscal year 2025 were admission to the DAX index, the award of one of the largest contracts in the company’s history, and streamlining of the corporate structure.

This photo shows an aerial view of the SmartParc factory

How SmartParc is rewriting the rules of food production

Thanks to a new SmartParc manufacturing site, food processors in the U.K. are cutting their running costs and emissions. With GEA heating and cooling technology at its core, this collaborative production model demonstrates how innovation is accelerating the industry’s net-zero ambitions.

Sushi dish made with the ingredient Bioalbumen®, an egg-white protein (ovalbumin) (Onego Bio)

Il laboratorio di scienze alimentari

"Fare le uova come la birra". Un paragone che prima fa sorridere e poi riflettere: in effetti è il modo più semplice per spiegare qualcosa di molto complesso. Attraverso questo breve filmato girato nel cuore agricolo degli Stati Uniti, scopriamo la fermentazione di precisione e il lavoro concreto necessario per trasformare un'idea in cibo.

Ricevi notizie da GEA

Resta in contatto con le innovazioni e le storie GEA iscrivendoti alle news di GEA.

Contattaci

Siamo qui per aiutarti! Solo pochi dettagli e saremo in grado di rispondere alla tua richiesta.